Skip to content

Clinical trials

Phase 1 Ischemic Stroke trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 1 Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20161
20171
20212
20222
20236
20245
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Not yet recruiting5
Unknown status5
Recruiting4
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capital Medical University4
Changzhou Qianhong Bio-pharma Co., Ltd.2
Tianjin Huanhu Hospital2
Zhujiang Hospital2
Allife Medical Science and Technology Co., Ltd.1
BOE Technology Group Co., Ltd.1
Beijing Suncadia Pharmaceuticals Co., Ltd1
Beijing Tiantan Hospital1
Chendu DIAO Nine Hong Pharmaceutical Factory1
Fujian Shengdi Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke27
Stroke4
Acute Coronary Syndrome1
Atrial Fibrillation1
Brain Edema1
Bronchiolitis Obliterans Syndrome1
Cerebral Hemorrhage1
Pneumonia, Ventilator-Associated1
Thrombosis1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.